Pay in 4 interest-free payments of $24.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Pretreatment with tangeretin inhibites IL-1beta-induced p38 MAPK
Morinibu A
CNX-1351 potently inhibited PI3Kα and was 20−400 times less potent against β
InChi: InChI=1S/C12H8N4O6S/c13-23(21
PJ34 - CAS# 344458-19-1 e O-desmethyl Mebeverine acid Pretreatment with tangeretin inhibites IL-1beta-inducedPJ 34 is a novel and potent PARP 1 inhibitor with potential anticancer activity. PJ34 has a high affinity for PARP 1 (IC(50) = 20 nM). PJ 34 inhibits PARP 1 expression and ERK phosphorylation in glioma conditioned brain microvascular endothelial cells. PJ 34 reduces mesenteric vascular injury induced by experimental cardiopulmonary bypass with cardiac arrest. PJ 34 reduce cell inflammation and damage that follow PARP 1 overexpression. PJ 34 negatively